Related references
Note: Only part of the references are listed.Koumine ameliorates concanavalin A-induced autoimmune hepatitis in mice: involvement of the Nrf2, NF-KB pathways, and gut microbiota
Wancai Que et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2023)
Opiate Antagonists for Chronic Pain: A Review on the Benefits of Low-Dose Naltrexone in Arthritis versus Non-Arthritic Diseases
Praneet Dara et al.
BIOMEDICINES (2023)
Epidemiology and surveillance of autoimmune hepatitis in Asia
Tomohiro Katsumi et al.
LIVER INTERNATIONAL (2022)
Immune-responsive gene 1 protects against liver injury caused by concanavalin A via the activation Nrf2/HO-1 pathway and inhibition of ROS activation pathways
Wenchang Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Cucurbitacin E glucoside alleviates concanavalin A-induced hepatitis through enhancing SIRT1/Nrf2/HO-1 and inhibiting NF-κB/NLRP3 signaling pathways
Gamal A. Mohamed et al.
JOURNAL OF ETHNOPHARMACOLOGY (2022)
Curcumin alleviates lipopolysaccharides-induced inflammation and apoptosis in vascular smooth muscle cells via inhibition of the NF-kappa B and JNK signaling pathways
Haohang Ruan et al.
INFLAMMOPHARMACOLOGY (2022)
Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice
Mahmoud Elshal et al.
INFLAMMOPHARMACOLOGY (2022)
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition
Devesh Tewari et al.
CURRENT NEUROPHARMACOLOGY (2021)
Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition
Maha H. Sharawy et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway
Koji Ishida et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)
Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of imaging? A clinicoradiological review
Natalia Borges Nunes Gomes et al.
CLINICAL IMAGING (2021)
Daidzein ameliorated concanavalin A-induced liver injury through the Akt/GSK-3β/Nrf2 pathway in mice
Shang-Lin Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study
Emmanuel Monnet et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Naltrexone (NTX) relieves inflammation in the collagen-induced- arthritis (CIA) rat models through regulating TLR4/NFκB signaling pathway
Neili Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Montelukast ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting TNF-α/JNK signaling pathway
Dalia H. El-Kashef et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
(+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors
Eva M. Medina-Rodriguez et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis
Weiwei Ji et al.
INFLAMMOPHARMACOLOGY (2019)
Anti-inflammatory effects of Chinese propolis in lipopolysaccharide-stimulated human umbilical vein endothelial cells by suppressing autophagy and MAPK/NF-B signaling pathway
Hongzhuan Xuan et al.
INFLAMMOPHARMACOLOGY (2019)
Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies
Elisabeth Sucher et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
Zijian Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Novel therapeutic targets in autoimmune hepatitis
Richard Taubert et al.
JOURNAL OF AUTOIMMUNITY (2018)
Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species
Fatma Mounieb et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2017)
Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligends for Intracellular Toll-Like Receptors
Rachel Cant et al.
FRONTIERS IN IMMUNOLOGY (2017)
Implication of Nrf2/HO-1 pathway in the coloprotective effect of coenzyme Q10 against experimentally induced ulcerative colitis
Ahmed E. Khodir et al.
INFLAMMOPHARMACOLOGY (2017)
Methane-rich saline protects against concanavalin A-induced autoimmune hepatitis in mice through anti-inflammatory and anti-oxidative pathways
Rong He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Protective effect of Rabdosia amethystoides (Benth) Hara extract on acute liver injury induced by Concanavalin A in mice through inhibition of TLR4-NF-κB signaling pathway
Ke-Feng Zhai et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway
Yan Zhuang et al.
PLOS ONE (2016)
Relation between TLR4/NF-B signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability
Simona Gargiulo et al.
AGING CELL (2015)
Molecular mechanisms of the protective role of wheat germ oil against cyclosporin A-induced hepatotoxicity in rats
El-Sayed Akool
PHARMACEUTICAL BIOLOGY (2015)
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
Jarred Younger et al.
CLINICAL RHEUMATOLOGY (2014)
Proapoptotic Effects of the Chemokine, CXCL 10 Are Mediated by the Noncognate Receptor TLR4 in Hepatocytes
Hacer Sahin et al.
HEPATOLOGY (2013)
Dragon's Blood Inhibits Chronic Inflammatory and Neuropathic Pain Responses by Blocking the Synthesis and Release of Substance P in Rats
Yu-Sang Li et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2012)
The benefit of animal models for autoimmune hepatitis
Elmar Jaeckel et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords
Shinn-Long Lin et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Inhibition of Immune-Mediated Concanavalin A-Induced Liver Damage by Free-Radical Scavengers
Haim Shirin et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Induction of Hepatitis by JNK-Mediated Expression of TNF-α
Madhumita Das et al.
CELL (2009)
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
Mark R. Hutchinson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Naloxone treatment in opioid addiction: the risks and benefits
Eveline L. A. van Dorp et al.
EXPERT OPINION ON DRUG SAFETY (2007)
A novel inhibitory effect of naloxone on macrophage activation and atherosclerosis formation in mice
Shu-Lin Liu et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats
M. R. Ebrahimkhani et al.
GUT (2006)
Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature
C Brewer et al.
ADDICTION BIOLOGY (2004)